ClearPoint Neuro, Inc. (CLPT) stock
CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3021% above fair value
$8.48−0.01 (-0.12%)
Close on Nov 13, 2026Market cap $271.82MP/E –Yield –
ClearPoint Neuro ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
ClearPoint Neuro's ebitda for the twelve months ending Sep 30, 2026 was -$31.51M. For fiscal 2025 it was -$23.35M. The highest annual figure on record is -$2.71M in fiscal 2012.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$23.35M | – |
| FY2024 | Dec 31, 2024 | -$18.75M | – |
| FY2023 | Dec 31, 2023 | -$21.82M | – |
| FY2022 | Dec 31, 2022 | -$16.09M | – |
| FY2021 | Dec 31, 2021 | -$13.22M | – |
| FY2020 | Dec 31, 2020 | -$5.89M | – |
| FY2019 | Dec 31, 2019 | -$4.45M | – |
| FY2018 | Dec 31, 2018 | -$5.14M | – |
| FY2017 | Dec 31, 2017 | -$6.22M | – |
| FY2016 | Dec 31, 2016 | -$7.33M | – |
| FY2015 | Dec 31, 2015 | -$8.76M | – |
| FY2014 | Dec 31, 2014 | -$4.94M | – |
| FY2013 | Dec 31, 2013 | -$7.05M | – |
| FY2012 | Dec 31, 2012 | -$2.71M | – |
| FY2011 | Dec 31, 2011 | -$5.57M | – |
| FY2010 | Dec 31, 2010 | -$9.25M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$6.23M | – |
| Q2 FY2026 | Jun 30, 2026 | -$10.09M | – |
| Q1 FY2026 | Mar 31, 2026 | -$8.39M | – |
| Q4 FY2025 | Dec 31, 2025 | -$6.80M | – |
| Q3 FY2025 | Sep 30, 2025 | -$5.21M | – |
| Q2 FY2025 | Jun 30, 2025 | -$5.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$6.06M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.40M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.89M | – |
| Q2 FY2024 | Jun 30, 2024 | -$4.49M | – |
| Q1 FY2024 | Mar 31, 2024 | -$3.97M | – |
| Q4 FY2023 | Dec 31, 2023 | -$4.52M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.74M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.98M | – |
| Q1 FY2023 | Mar 31, 2023 | -$5.58M | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.76M | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.10M | – |
| Q1 FY2022 | Mar 31, 2022 | -$3.78M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.94M | – |
| Q3 FY2021 | Sep 30, 2021 | -$3.75M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.36M | – |
| Q1 FY2021 | Mar 31, 2021 | -$2.17M | – |
| Q4 FY2020 | Dec 31, 2020 | -$2.10M | – |
| Q3 FY2020 | Sep 30, 2020 | -$1.22M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.42M | – |
| Q1 FY2020 | Mar 31, 2020 | -$1.15M | – |
| Q4 FY2019 | Dec 31, 2019 | -$1.38M | – |
| Q3 FY2019 | Sep 30, 2019 | -$874.82K | – |
| Q2 FY2019 | Jun 30, 2019 | -$1.26M | – |
| Q1 FY2019 | Mar 31, 2019 | -$937.61K | – |
| Q4 FY2018 | Dec 31, 2018 | -$950.79K | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.18M | – |
| Q2 FY2018 | Jun 30, 2018 | -$1.61M | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.40M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.81M | – |
| Q3 FY2017 | Sep 30, 2017 | -$1.30M | – |
| Q2 FY2017 | Jun 30, 2017 | -$1.79M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.32M | – |
| Q4 FY2016 | Dec 31, 2016 | -$1.76M | – |
See a number that looks wrong?